Detalhe da pesquisa
1.
Consequences of hemophagocytic lymphohistiocytosis-like cytokine release syndrome toxicities and concurrent bacteremia.
Pediatr Blood Cancer
; 68(10): e29247, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309174
2.
A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.
Blood Adv
; 7(15): 4218-4232, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36607839
3.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 4(10): 101212, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774704
4.
An optimized bicistronic chimeric antigen receptor against GPC2 or CD276 overcomes heterogeneous expression in neuroblastoma.
J Clin Invest
; 132(16)2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852863
5.
Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma.
J Cell Immunol
; 3(5): 305-316, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35464627
6.
ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors.
Cancer Discov
; 11(9): 2216-2229, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741711
7.
Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.
Cell Rep
; 37(8): 110047, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818552
8.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 5(5): 101586, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723625
9.
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Nat Genet
; 51(4): 694-704, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926971
10.
Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability.
PLoS One
; 13(11): e0208324, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30500859
11.
Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy.
Leukemia
; 34(11): 3064-3069, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103145